CannabisNewsBreaks Archive - Page 74 of 429

ThursdayNov 18, 2021 2:13 pm

CannabisNewsBreaks – AmeriCann (ACAN) Announces 300% Annual Revenue Increase from Flagship Project

AmeriCann (OTCQB: ACAN), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, today announced financial and operational updates for its flagship project, the Massachusetts Cannabis Center. Located on a 52-acre parcel in southeastern Massachusetts, the project is permitted for 987,000 sq. ft. of cannabis cultivation and processing infrastructure, which is being developed in phases to support multiple tenants in medical and adult-use cannabis markets. “AmeriCann’s operating revenue for the year ending September 2021 increased by over 300% from the prior year,” said CFO Ben Barton. “The strong top-line growth reflects four consecutive quarters of accelerating revenue. We…

WednesdayNov 17, 2021 2:36 pm

CannabisNewsBreaks – Global Technologies Ltd (GTLL) Announces LOI to Acquire Tersus Power

Global Technologies (OTC: GTLL), a holding corporation with operations engaged in the online sales of CBD and hemp-related products, the acquisition of intellectual property in the safety and security space, and as a portal for entrepreneurs to provide immediate access to live shopping, e-commerce, distribution and logistics, today announced its entry into a letter of intent to acquire Tersus Power. Tersus is focused on designing a safe, adaptable and affordable hydrogen fueling station that allows for rapid development and deployment of hydrogen fueling infrastructure while minimizing the risk to investors. “This is an exciting time for the Global Technologies shareholders,”…

WednesdayNov 17, 2021 1:57 pm

CannabisNewsBreaks – Way2Grow Biopharma Corp. Enters ‘Next Phase of Life Science Therapeutics’

Way2Grow (“W2G”), a privately held therapeutic corporation existing under the laws of British Columbia, today announced approval of a Health Canada Dealer’s Licence Application. Under the approval, Health Canada issued notice to W2G to complete the construction of a level 8 secure environ and psilocybin production campus. The license and production facility will allow W2G to procure psychedelics as well as propagate, cultivate, harvest and sell psychedelics to pharmacies, clinics and other licenced research facilities for allowable research purposes pursuant to the Controlled Drugs and Substances Act (the “CDSA”). “We are excited to enter this next phase of life science…

TuesdayNov 16, 2021 3:06 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Working on Answer to Mass Production of Rare, Otherwise Depleted Cannabinoid Opportunities

InMed Pharmaceuticals (NASDAQ: INM) and its subsidiary BayMedica are innovators in the field of rare cannabinoids, making them available for consumer access. InMed specializes in developing a proprietary biosynthesis system to manufacture pharmaceutical-grade cannabinoids that are otherwise too rare to be acquired in abundance. Through BayMedica, its recent acquisition, InMed also has capabilities in both yeast biosynthesis and chemical synthesis, catering to the large and growing health and wellness consumer markets. “The cannabis plant is made up of over 100 unique cannabinoids, many of which are only found in trace amounts,” reads a recent article. “With so many of these…

MondayNov 15, 2021 11:30 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes Acquisition of Vessel Brand Inc.

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has completed the acquisition of Vessel Brand Inc., an industry leader in cannabis consumer technology. According to Flora Growth, the acquisition provides the company with an immediate foothold in the North American cannabis market because Vessel brings with it a trailing 12-months revenue of $6.6 million and year-over-year growth of 90%. In addition, the acquisition diversifies Flora’s premium brand portfolio through Vessel’s strong position in the luxury cannabis consumer technology market. According to the announcement, key Vessel team members will join Flora’s executive bench and…

FridayNov 12, 2021 11:35 am

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Eyeing Q1 2022 Delivery of Highest-Quality Retail Products from Florida Grow Operations

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) recently completed phase one of an aggressive three-phase development strategy for its Florida facilities, located in Apopka and Sanderson. Phase one entailed the rapid development of the Apopka facility. RWB also announced that it had commenced operation in late September after receiving regulatory approval to begin cultivation. “The initial licensed area in Apopka is capable of producing 85g of flower per plant, translating to projected annual revenue in excess of $10 million. The Apopka facility will supply RWB’s phase two of the strategy, which entails activating thirty 16’ by 40’ customized,…

ThursdayNov 11, 2021 1:33 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Enters into Cannabinoid Science

Flora Growth Corp. (NASDAQ: FLGC) recently announced the next stage of its development with the creation of Flora Pharma and the execution of an agreement to begin scientific clinical trials globally. Flora Pharma’s formation follows the acknowledgment and commitment by the management team and board of directors to move ahead with applied research initiatives in medical cannabis in order to become a leader in the discovery, development, manufacturing and commercialization of novel, phytocannabinoid-based prescription medicines and nutraceutical products to address a broad range of diseases. The company also signed an agreement to begin scientific clinical trials on the use of…

ThursdayNov 11, 2021 12:32 pm

CannabisNewsBreaks – Why Cannabis Strategic Ventures Inc. (NUGS) Is ‘One to Watch’

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, is guided by the vision to acquire and scale assets in the legal cannabis market while achieving efficiencies through economies of scale and vertical integration. “Cannabis Strategic Ventures recently expanded its portfolio by completing the transfer process for cultivation, retail, distribution and manufacturing licenses issued by the city of Los Angeles and the state of California, and it is now working toward taking operational control of each license,” reads a recent article. Its brand portfolio includes NUGS, the NUGS Farm North and MDRN Tree. NUGS provides emerging…

WednesdayNov 10, 2021 1:29 pm

CannabisNewsBreaks – IBN Announces Collaboration for Upcoming Lift & Co. Expo

IBN (“InvestorBrandNetwork”), an innovative corporate communications firm and content distributor, today announced that it will serve as media sponsor for the Lift & Co. Expo. Well-known for becoming Canada’s biggest event for cannabis consumers, industry professionals, investors and the media, this year’s Lift & Co. Expo is set to take place at Toronto’s Metro Toronto Convention on Nov. 18-21, 2021. Returning in an in-person format, the event will feature upwards of 250 exhibitors from around the world and bring together Canada’s top business leaders, innovators and regulators to share their perspectives and approaches on the most important issues facing Canada’s…

WednesdayNov 10, 2021 11:17 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands 2022 R&D Programs to Evaluate Potential Treatment Options for Alzheimer’s and Diabetes

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its plans for several new and ongoing DehydraTECH(TM)-applied R&D programs for 2022. According to the update, the studies mentioned in the announcement represent only a fraction of Lexaria's 2022 work programs. “Calendar 2022 will continue to see significant milestones in utilizing DehydraTECH-CBD for investigation of heart disease and hypertension; and separately, for oral nicotine delivery as an alternative to smoking,” said Chris Bunka, CEO of Lexaria Bioscience Corp. “We are delighted to announce that DehydraTECH as an enhanced drug delivery platform will also be evaluated for…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

CannabisNewsBreaks